Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CEO of Risk Intelligence purchases 90,000 shares

On the 1 July the CEO of Risk Intelligence (RISK.SS), Hans Tino Hansen announced a purchase of 90,000 shares (83,342 warrants executed at DKK 3.00 and 6,658 shares acquired in the market at value weighted average price of DKK 5.20) equal to a total amount of DKK 289,904.Risk Intelligence CEO Hans Tino Hansen says:As an insider I only have certain windows of opportunity when to conduct trade in the Risk Intelligence share. I have taken this opportunity to further invest in the future growth of Risk Intelligence. Hans Tino Hansen’s total shareholdings after this transaction are 3,100,000

Acquisition between Valio and Heinon Tukku is approved

On 30.6.2021 the Finnish Competition and Consumer Authority (FCCA) approved the transaction in which Valio Oy is acquiring Heinon Tukku Oy. With the transaction, Valio becomes an even more comprehensive partner for food industry professionals.“We are really pleased with the FCCA’s decision. Going forward, we will be a more comprehensive partner to those food industry professionals for whom quality, a deep understanding of customer needs, and delivery reliability are key factors. Heinon Tukku is a traditional family-owned company, and Valio is owned by Finnish dairy farmers. We share a

Monetary policy decision: Zero interest rate and asset purchases for inflation to be more permanently close to 2 per cent

The spread of infection of the coronavirus has declined and the economic outlook is brighter. However the pandemic is not yet over, and inflationary pressures are still moderate. By conducting an expansionary monetary policy, the Riksbank contributes to continued good development of the economy and to inflation attaining the target more permanently. The Executive Board has therefore decided to hold the repo rate unchanged at zero per cent and that during the fourth quarter the Riksbank will continue purchasing assets within the envelope of SEK 700 billion.Rising optimism, but great

Invitation to the presentation of Axfood’s second quarter 2021

Axfood invites investors, analysts and the press to a presentation of the interim report for the second quarter 2021 at 9:30 am CET on 15 July. The report will be published at 7:00 am CET the same day.Axfood’s President and CEO Klas Balkow will present the report together with CFO Anders Lexmon. The presentation will be held in English.Time: Thursday, 15 July at 9:30 am CETTo participate, please dial in:Sweden: +46 8 519 993 83The UK: +44 333 300 9268The US: +1 833 823 0586The presentation can also be followed live via webcast at axfood.com .

BioStock: Saniona’s CMO on the new clinical trial with SAN711

Saniona has generated promising preclinical data with SAN711 in multiple models of pain and rare neuropathic disorders. BioStock reached out to Rudolf Baumgartner, MD, Chief Medical Officer and Head of Clinical Development at Saniona, to learn more about the newly-initiated phase I safety study in healthy volunteers.Read the full article at biostock.se: https://www.biostock.se/en/sanionas-cmo-on-the-new-clinical-trial-with-san711/This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Cyxone and Medical University of Vienna announce collaboration to study broader T20K use in MS

After identifying some valuable new potential treatments for T20K, Cyxone AB (publ) (“Cyxone or the Company”) today announced that the company has entered into a research collaboration with Prof. Christian Gruber, the inventor of T20K & Prof. Gernot Schabbauer from the Medical University of Vienna. The aim of the study is to deepen the understanding of the mode of action (MoA) of T20K and to explore these new uses and the potential to provide significant additional therapeutic benefit in a model for multiple sclerosis. The study will start later this month, with planned readout in June 2022,

Utsikt Bredband choose Waystream

Utsikt Bredband AB places order worth millions Swedish crowns for a three-digit number of switches for its business. The products include units from 1 to 10 Gbits/s and enables Utsikt to offer super fast and stable broadband to its end customers.Press release July 1, 2021 Utsikt Bredband, part of Tekniska verken in Linköping AB, operates and develops an open, neutral city network for more than 65,000 households and companies in the municipalities of Linköping, Mjölby, Katrineholm, and parts of Motala municipality. Utsikt's ambitious vision is to build the world's most digitalised region

First transaction in the ECIT´s specialized 24SevenOffice technology unit

24SevenOffice partner ECIT AS has established a strategic business unit specialized on 24SevenOffice technology including AI accounting, and best practice. ECIT is an accounting and IT service provider with proforma 2020 revenue of NOK 2 billion and 2,100 employees across 9 countries. ECIT has now announced the first transaction in this partnership where the Norwegian 24SevenOffice tech savvy and AI enabled accounting firm, Value Group, is the first company to join ECIT´s business unit with focus on 24SevenOffice technology.  “It is great news that ECIT has closed the first accounting

Invitation to presentation of Bravida’s report for the second quarter 2021

Bravida’s report for the second quarter 2021 will be published 07:30 CET on 16 July 2021.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Åsa Neving. The presentation will be held in English and can be followed on the web or on the phone. There will be room for questions in the telephone conference. Link to webcasthttps://tv.streamfabriken.com/bravida-q2-2021 Telephone conference dial-in numberSE:  +46850558356    (Local call) UK:  +443333009264  (Local call) US:  +1 6319131422   (Local call. PIN:22491044#) The report and

Wärtsilä’s leadership in Cargo Handling Systems emphasised with order to supply four gas carriers at DSME

Wärtsilä Corporation, Press release, 1 July 2021 at 10:00 AM EESTThe technology group Wärtsilä will supply its advanced Cargo Handling System  for four new 91,000 cbm capacity Very Large Gas Carrier (VLGC) vessels being built for the Norway-based fleet owner Avance Gas. The ships are under construction at the Daewoo Shipbuilding & Marine Engineering (DSME) yard in South Korea. The orders with Wärtsilä were placed by DSME in April and May 2021.  “Wärtsilä is the world’s largest supplier of complete cargo handling systems for gas carriers, and there is a good

Presentation of Intrum’s results for April-June 2021

Intrum announces its interim results for April-June 2021 on 22 July, 2021 at 7:00 a.m. CET. The report will be presented in a audio cast with telephone conference at 9:00 a.m. CET the same day.Anders Engdahl, President & CEO, and Michael Ladurner, CFO, will present the results and answer questions. The conference will be held in English. To listen in to the conference live, please dial: +46 8 505 583 73 (SE)+44 33 3300 9266 (UK)+1 646 722 4904 (US) Link to live audio cast   The link to the live audio cast is also available on www.

Bambuser Partners with Digital Agency oddity to Elevate Live Video Shopping Across the DACH Region

[Joint image of CEO Bambuser and Managing Director oddity] Stockholm - 1 July 2021 - Bambuser and oddity group , the German-based creative and digital marketing agency, today announced a partnership that will bring Live Video Shopping to more brands and retailers in the DACH region. The partnership will combine the technical expertise of Bambuser, recent winner of the LVMH Innovation Award, with oddity’s deep insights into strategies for driving success across the entire customer journey. The teams within the oddity group that specialize in consumer and channel

Cantargia advances development of nadunolimab in triple negative breast cancer through submission of clinical protocol for TRIFOUR study

Cantargia AB today announced the submission of the clinical trial application for TRIFOUR, a phase Ib/II trial investigating nadunolimab (CAN04) combined with gemcitabine and carboplatin for treatment of triple negative breast cancer (TNBC). After an initial safety lead in, the study will include a randomized phase II part. This trial will be performed in Spain in collaboration with the Spanish Breast Cancer Group, GEICAM. Up to 120 patients may be included and the first patient is estimated to be enrolled in November 2021.The antibody CAN04, binding to interleukin-1 receptor accessory

Volvo Penta starts production of E-driveline for world’s first serial electric fire truck

Volvo Penta has commenced production of bespoke electric drivelines for leading fire service vehicle manufacturer Rosenbauer’s pioneering fire truck, named “Revolutionary Technology” (RT).“We announced our emob partnership with Rosenbauer  in 2019, and we have gone from concept to start of production in record time,” says Giorgio Paris, President of Volvo Penta Industrial. “This is a milestone in our electrification journey. We see a growing demand for electric solutions in the market today

SaltX in cooperation agreement with ABB

- Strengthens the technical platform with system for automation and control Nasdaq First North-listed SaltX Technology has signed a letter of intent with ABB regarding cooperation in systems for automation and control processes to strengthen SaltX's technical platform of EnerStore.The companies will jointly ensure a stable and scalable control system to strengthen SaltX's technical platform. ABB has a long and solid experience in complex control systems and will be able to contribute to optimizing and securing the automation and control system in both the short and long term for the

New CEO in Centiglobe - Centiglobe has appointed Petter Sandgren as new CEO. Petter will succeed Henrik Gradin who takes on the role as Chief Strategy Officer.

Centiglobe Technologies is an innovative fintech company offering a blockchain based platform enabling cross-border payments in real-time.Henrik Gradin - I am proud of how Centiglobe has evolved and been able to create a cutting edge blockchain technology that enables international payments in real time. We now take the next step in commercialization and it is a good time for new leadership. This gives me the opportunity to spend more time with strategy and business development to further develop the Centiglobe platform and to ensure Centiglobe stays in the forefront. Petter has

BioStock: First impressions from Alligator’s new CEO

In June 2021, Søren Bregenholt began his new role as CEO for Lund-based company Alligator Bioscience. The company is about to initiate a phase II trial with mitazalimab, and drug candidate ATOR-1017 is soon to follow. Other projects are also advancing, and BioStock had the opportunity to talk to Bregenholt about his first impressions and what he expects to achieve as CEO of Alligator.Read the full interview with Alligator Bioscience's CEO Søren Bregenholt at biostock.se: https://www.biostock.se/2021/07/first-impressions-from-alligators-new-ceo/ This is a press release from BioStock -

2cureX and University Hospital of Hamburg-Eppendorf present IndiTreat data at ESMO GI for early-stage Pancreatic Cancer

2cureX announces the presentation of the poster [P-288] “Individual Drug Screening and heterogeneity analysis of patient derived tumoroids – Roadmap to improving therapy in Pancreatic Cancer” at the 2021 ESMO World Congress on Gastrointestinal Cancer (ESMO GI) starting yesterday. The poster is presented jointly with the University Hospital of Hamburg - Eppendorf (UKE - Hamburg, Germany) as part of a collaboration to bring Functional Testing to Pancreatic Cancer.The poster confirms the feasibility of using Functional Testing on resected tissue samples coming from the primary tumor, opening

BioStock: 2021 represents beginning of new era for Fluicell

As we head into the summer, BioStock takes a look at Fluicell’s achievements so far this year. Standing out are the company’s launch of their latest product, Biozone 6, and its dive into the regenerative medicine field through its BioRej Advance programme. BioStock spoke with Fluicell’s CEO Victoire Viannay to get her thoughts on the company’s new direction and what milestones Fluicell has its sights on for the rest of 2021.Read the interview with Victoire Viannay at biostock.se: https://www.biostock.se/en/2021-represents-beginning-of-new-era-for-fluicell/ This is a press release from

Carbiotix evaluation of new production enzyme yields positive results

Carbiotix (publ) ("Carbiotix" or “the Company”) today announces that it has completed a comprehensive evaluation of a new production enzyme supplied by a potential strategic partner yielding positive results. The Company will now proceed with the GRAS Self Affirmation process.Carbiotix communicated at the end of Q1 2021 that it would undertake a comprehensive evaluation of a new production enzyme supplied by a leading global enzyme producer and potential strategic partner in Q2 2021. This enzyme had the potential to accelerate achieving FDA GRAS No Objection and EFSA Novel Foods status in

Today Australian hygiene company Asaleo Care becomes Essity

Hygiene and health company Essity has today finalized its acquisition of the remaining 63.8% of the shares in the Australian hygiene company Asaleo Care. Essity AustralAsia, which is the name of the regional unit going forward, will be consolidated into Essity’s accounts as of July 1[st ], 2021.“It is with great pleasure we today welcome our new colleagues in Australia, New Zealand and the Pacific Islands to Essity. Together we will continue to improve well-being through our leading products and solutions and facilitate the opportunity for profitable growth in this region”, says Magnus

Beijer Ref becomes the majority owner of Fenagy A/S

Beijer Ref has entered into an agreement to increase its holding in the Danish refrigeration technology company Fenagy A/S. With an investment of DKK 19 million, Beijer Ref expands its ownership to just over 50 percent and thus becomes the majority shareholder. The company will be included in the financial accounts as of July 1, 2021, and will have a minor impact on the company’s earnings and position. The investment gives Fenagy the financial conditions necessary to strengthen the organization and meet the needs of the market. Beijer Ref made its first investment in Fenagy in

Will Martin Assumes Role as President and Chief Executive Officer of IRRAS

Stockholm, July 1, 2021 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that Will Martin has formally assumed the role of President and Chief Executive Officer (CEO), which comes as part of a planned succession process first announced in April 2021. Kleanthis G. Xanthopoulos, Ph.D., will step down as CEO and will remain on the Company’s Board of Directors. Will Martin joined IRRAS as Chief Commercial Officer in 2018. Prior to IRRAS, he most recently served as General Manager of the

Change in Konecranes Leadership Team

KONECRANES PLC STOCK EXCHANGE RELEASE July 1, 2021 at 9:30 EEST Change in Konecranes Leadership Team Timo Leskinen, SVP for Human Resources and a member of the Konecranes Leadership Team, has decided to leave the company and will take a position at another company. He will leave Konecranes on 30 September 2021. “Timo has been a highly valued member of our Konecranes Leadership Team during the past eight years. I want to thank Timo for all his contributions at Konecranes and wish him the best of luck in his future career”, says Rob Smith, President and CEO of Konecranes.

There are no items matching the current filter
There are no more items matching the current filter
Back to top